Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2015Cited by 35
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyTaiki Ando, Hideaki Nakajima, Taisei Suzuki et al.|International Journal of Hematology|2020Cited by 30
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Hideaki Nakajima, Shin Fujisawa et al.|Asia-Pacific Journal of Clinical Oncology|2018Cited by 7
Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective studyTakayuki Sakuma, Hideaki Nakajima, Shin Fujisawa et al.|Hematological Oncology|2023Cited by 6
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantationTakayoshi Tachibana, Hideaki Nakajima, Takuya Miyazaki et al.|Cytotherapy|2024Cited by 4